CRH vs FCX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CRH exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and financial stability. While the current price of $118.00 trades at a significant premium to its Graham Number ($66.71), it remains well below its growth-based intrinsic value of $162.54. The company is outperforming its sector in valuation (P/E 21.42 vs Sector Avg 37.99) and profitability, supported by an impressive 48.4% YoY earnings growth. Despite a bearish technical trend, the strong analyst consensus and healthy balance sheet suggest a compelling long-term value proposition.
FCX shows bearish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
CRH vs FCX: Head-to-Head Comparison
This page compares CRH plc (CRH) and Freeport-McMoRan Inc. (FCX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.